 |
 |
-----Oorspronkelijk bericht----- Van: Renee Marton <[log in to unmask]> Aan: [log in to unmask] <[log in to unmask]> Datum: donderdag 2 september 1999 20:59 Onderwerp: Re: coenzyme Q10 and NADH >>> but what is NADH? <<< Date: Wed, 24 Feb 1999 00:09:13 -0500 From: judith richards <[log in to unmask]> Subject: News-ENADA for CFS/Parkinsons/Alzheimers http://biz.yahoo.com/bw/990223/bw0094_2.html Company Press Release ENADA - A Nutritional Supplement for Healthy Individuals Desiring More Natural Energy A Clinical Trial Reports Proven Energy Enhancement Using Strict FDA Testing Guidelines to Alleviate Symptoms of Chronic Fatigue Syndrome WASHINGTON, D.C.--(BUSINESS WIRE)--Feb. 23, 1999-- Menuco Corporation announced today that ENADA®, a natural energy-enhancing nutritional supplement, tested by researchers at Georgetown University Medical Center, has achieved significant improvement in relieving the symptoms of people suffering from Chronic Fatigue Syndrome (CFS). CFS is a debilitating disorder caused by unexplainable tiredness or lack of energy, and has no known cure. According to the Centers for Disease Control, over 14 million people in the U.S. experience chronic fatigue symptoms. The Georgetown clinical trials focused on people diagnosed with CFS; however, ENADA is also a nutritional supplement for healthy individuals who desire additional energy. ENADA is one of the first nutritional supplements to be tested using strict FDA guidelines to determine its safety and effectiveness. Georgetown doctors found that 31% of the patients who took ENADA achieved significant improvement in the relief of their symptoms. In a follow-up study, 72% of the patients achieved positive results over a longer period of time. The double-blind, placebo-controlled human clinical trial results have recently been published in a prominent medical peer-reviewed journal called ``Annals of Allergy, Asthma and Immunology.'' The findings of these clinical trials are being presented at the February 23, 1999 press conference at Georgetown University Medical Center. ``Eighty percent of Americans state that fatigue is their number one health complaint. We to demonstrate through sound scientific studies, not marketing hype, that ENADA is both safe and effective in providing energy enhancement to alleviate the symptoms of CFS, a debilitating disorder which affects half a million Americans,'' said Matt Fitzsimmons, president, Menuco Corporation. ``Dr. Bellanti and his research colleagues at Georgetown University Medical Center have successfully demonstrated ENADA's effectiveness in increasing energy,'' says Fitzsimmons. ENADA is the brand name for stabilized, absorbable NADH (nicotinamide adenine dinucleotide plus high-energy hydrogen). It is the only patented, stabilized, absorbable, oral form of NADH currently on the market. For years, research scientists have known that NADH a natural coenzyme plays an important role in the body's cellular energy producing function. NADH occurs naturally in the muscle tissue of fish, poultry and cattle - key food sources in the human diet. However, the human body absorbs miniscule amounts of NADH ingested from food sources. Also it is known that the more NADH a cell has, the more energy it can produce; therefore, the more energy a person has. In 1996, ENADA received an Investigative New Drug (IND) acceptance from the FDA allowing ENADA to begin a human double-blind, placebo-controlled, crossover study following strict pharmaceutical and drug testing guidelines. The protocol was recognized by the FDA and conducted at the prestigious Georgetown University Medical Center in Washington, DC. (The IND number is 49,635 and the original working name of the product was Birmadil.) ENADA is available from Menuco Corporation under the Menuco brand. Also, Menuco has selected a limited number of strategic partners to facilitate national distribution. To this end, the company has established marketing, private-labeling and distribution agreements with major retailers and companies including General Nutrition Center (GNC), KAL-Nutraceutical Corporation, Natrol, Inc., The Vitamin Shoppe, and Weider/Schiff Nutrition. Additionally, several important catalog organizations market ENADA, including Carotec and Pro-Health/CFIDS buyer's club. ``We are indeed excited about partnering with Menuco to market our own private-label version of Natrol® ENADA NADH to professional health stores,'' says Elliott Balbert, CEO, Natrol, Inc. ``Our customers are seeking the highest quality supplements supported by scientific studies. Natrol's ENADA is certainly one of those products. We are glad to be providing our customers with this stabilized, patented, oral form of NADH,'' says Balbert. Georgetown researchers are planning a large scale Chronic Fatigue Syndrome study using ENADA to further explore its effectiveness for CFS. Also, Georgetown researchers are conducting an FDA approved clinical trial testing ENADA to prevent the mental deterioration, memory lapses, and concentration difficulties associated with Alzheimer's disease. This study is being conducted under the direction of the department of neurology at Georgetown University Medical Center. ENADA has shown promise in Europe when used for patients with Alzheimer's and PARKINSON'S diseases. Birkmayer Laboratories in Vienna, Austria and Menuco Corporation sponsored the CFS study using ENADA. Georg Birkmayer, MD, Ph.D., world-renowned biochemical researcher and director of the Birkmayer Institute for Parkinson Therapy, developed the first stabilized, absorbable oral NADH supplement, a result of a decade of research. He is also the first to use NADH therapeutically to stimulate the body to produce naturally the key brain chemicals responsible for energy production and muscle coordination. ENADA is currently available in all health food stores in the United States, including GNC and The Vitamin Shoppe, and through catalog sales. ENADA is manufactured and packaged by Menuco through a licensing agreement with MERCK Pharmaceuticals in Austria - MERCK Kommanditgesellschaft Auf Aktien & Co. For additional information, visit these Web sites at http://www.enada.com and http://www.menuco.com. -- Judith Richards, London, Ontario, Canada <[log in to unmask]>